David P. Southwell, president and CEO of Inotek Pharmaceuticals, will participate at an ophthalmology panel at the 18th annual BIO CEO & Investor Conference.
Here are three quick notes:
1. The panel will take place in New York City at the Waldorf Astoria Hotel on Mon., Feb. 8, 2016, at 9:30 am EST.
2. The panel is titled “Advances in Ophthalmology: Therapies for Saving Sight” and will be moderated by Tony Gibney, managing director at Leerink Partners.
3. Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other eye diseases.